152 related articles for article (PubMed ID: 6108330)
1. Pentagastrin and glucagon stimulate serum somatostatin-like immunoreactivity in man.
Epstein S; Berelowitz M; Bell NH
J Clin Endocrinol Metab; 1980 Dec; 51(6):1227-31. PubMed ID: 6108330
[TBL] [Abstract][Full Text] [Related]
2. Stimulation tests for diagnosis of medullary thyroid carcinoma.
Sizemore GW; Go VL
Mayo Clin Proc; 1975 Feb; 50(2):53-6. PubMed ID: 1117754
[TBL] [Abstract][Full Text] [Related]
3. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum calcitonin levels after a 1-minute calcium injection and after pentagastrin injection in the diagnosis of medullary thyroid carcinoma.
Rude RK; Singer FR
J Clin Endocrinol Metab; 1977 May; 44(5):980-3. PubMed ID: 858780
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of somatostatin as a plasma tumor marker in medullary thyroid carcinoma.
Grauer A; Schroth J; Ziegler R; Raue F
Thyroid; 1995 Aug; 5(4):287-91. PubMed ID: 7488870
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin and calcitonin release from perfused dog thyroid lobes. Studies with calcium and pentagastrin.
Laurberg P
Endocrinology; 1984 Jun; 114(6):2234-41. PubMed ID: 6144539
[TBL] [Abstract][Full Text] [Related]
7. Plasma somatostatin in normal subjects and in various diseases: increased levels in somatostatin-producing tumors.
Saito H; Saito S
Horm Metab Res; 1982 Feb; 14(2):71-6. PubMed ID: 6121747
[TBL] [Abstract][Full Text] [Related]
8. Analysis of pentagastrin and calcium as thyrocalcitonin secretagogues in the early diagnosis of medullary carcinoma of the thyroid gland.
Linehan WM; Farrell RE; Cooper CW; Wells SA
Surg Forum; 1977; 28():110-2. PubMed ID: 617389
[No Abstract] [Full Text] [Related]
9. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
[TBL] [Abstract][Full Text] [Related]
10. Serum calcitonin after pentagastrin stimulation in patients with bronchogenic and breast cancer compared to that in patients with medullary thyroid carcinoma.
Samaan NA; Castillo S; Schultz PN; Khalil KG; Johnston DA
J Clin Endocrinol Metab; 1980 Aug; 51(2):237-41. PubMed ID: 6249833
[TBL] [Abstract][Full Text] [Related]
11. The effects of L-dopa on in vitro and in vivo calcitonin release from medullary thyroid carcinoma.
Baylin SB; Hsu TH; Stevens SA; Kallman CH; Trump DL; Beaven MA
J Clin Endocrinol Metab; 1979 Mar; 48(3):408-14. PubMed ID: 218991
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin-like immunoreactivity in transplantable medullary carcinoma of rat thyroid: partial chromatographic and biological characterization.
Berelowitz M; Cibelius M; Szabo M; Frohman LA; Epstein S; Bell NH
Endocrinology; 1980 Nov; 107(5):1418-24. PubMed ID: 6107240
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic evaluation of measurements of carboxyl-terminal flanking peptide (PDN-21) of the human calcitonin gene in human serum.
Ittner J; Dambacher MA; Born W; Ketelslegers JM; Buysschaert M; Albert PM; Lambert AE; Fischer JA
J Clin Endocrinol Metab; 1985 Dec; 61(6):1133-7. PubMed ID: 3902867
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin inhibits the pentagastrin-induced release of serum calcitonin in medullary carcinoma of the thyroid.
Gordin A; Lamberg BA; Pelkonen R; Almqvist S
Clin Endocrinol (Oxf); 1978 Apr; 8(4):289-93. PubMed ID: 647984
[TBL] [Abstract][Full Text] [Related]
15. Effect of a somatostatin analog (SMS 201-995) in perfusion on basal and pentagastrin-stimulated calcitonin levels in medullary thyroid carcinoma.
Modigliani E; Chayvialle JA; Cohen R; Perret G; Guliana JM; Vassy R; Roger P; Siame-Mourot C; Bennet M; Bentata-Pessayre M
Horm Metab Res; 1988 Dec; 20(12):773-5. PubMed ID: 2906036
[No Abstract] [Full Text] [Related]
16. Diagnosis of occult familial medullary carcinoma of the thyroid using pentagastrin.
Starling JR; Harris C; Granner DK
Arch Surg; 1978 Mar; 113(3):241-3. PubMed ID: 637688
[TBL] [Abstract][Full Text] [Related]
17. Plasma and tumor levels of somatostatin (SRIF) and somatostatin immunochemistry in medullary thyroid carcinoma: apparently discrepant preliminary results.
Franc B; Chayvialle JA; Modigliani E; Calmettes C; Caillou B; Dutrieux-Berger N; Houdent C; Kujas M
Henry Ford Hosp Med J; 1987; 35(2-3):147-8. PubMed ID: 2891647
[No Abstract] [Full Text] [Related]
18. Plasma somatostatin activity in medullary cancer of the thyroid.
Neradilová M; Nĕmec J; Zamrazil V; Bednár J; Pechová M; Soutorová M
Oncology; 1989; 46(6):378-80. PubMed ID: 2573874
[TBL] [Abstract][Full Text] [Related]
19. Pentagastrin, calcium and whisky stimulated serum calcitonin in medullary carcinoma of the thyroid.
Emmertsen KK; Nielsen HE; Mosekilde L; Hansen HH
Acta Radiol Oncol; 1980; 19(2):85-9. PubMed ID: 6254339
[TBL] [Abstract][Full Text] [Related]
20. Screening for medullary carcinoma of the thyroid in families with Sipple's syndrome: evaluation of new stimulation tests.
Telenius-Berg M; Almqvist S; Berg B; Hedner P; Ingemansson S; Tibblin S; Wasthed B
Eur J Clin Invest; 1977 Feb; 7(1):7-16. PubMed ID: 402280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
